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Abstract Dendritic cell (DC) maturation is essential for
the initiation of T-dependent immune responses. Nuclear
factor kappa B (NF-κB) transcription factors are ubiqui-
tously expressed signalling molecules, known to regulate
the transcription of a large number of genes involved in
immune responses, including cytokines and cell surface
molecules. In this work, we studied the time-dependent
activation of five members of the NF-κB family, p50, p52,
p65, RelB and cRel, in a mouse skin DC line in response
to stimulation with the strong sensitizer, 2,4-dinitrofluo-
robenzene (DNFB). Western blot assay revealed that ex-
posure of fetal skin DC (FSDC) to DNFB induced the
degradation of the inhibitor of NF-κB (IκB). Three out of
its five members, i.e. p50, p52, and RelB, were similarly
activated upon DNFB stimulation, with subsequent trans-
location of these subunits from the cytosol to the nucleus,
but with different kinetics. In contrast, p65 expression
was diminished in both the nucleus and the cytosol. The
electrophoretic mobility shift assay (EMSA) showed that
exposure of FSDC to DNFB induced DNA binding to 
NF-κB. Together, these results show that DNFB differen-
tially activates the various members of the NF-κB family
in skin DC.
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Introduction
Epidermal skin dendritic cells (DC), namely Langerhans
cells, are an important cell population involved in allergic
contact dermatitis and other cell-mediated immune reac-
tions due to their potent antigen-presenting capacity. They
capture the antigen and leave the epidermal environment,
migrating to the lymph nodes, where they come into con-
tact with and sensitize the T cells responsible for the adap-
tive immune response [14]. DC migration is a tightly reg-
ulated event, dependent on allergens and epidermal cyto-
kines, which also induce DC maturation with the expres-
sion of cell surface markers essential for antigen presenta-
tion, such as the major histocompatibility complex class II
molecules and costimulatory molecules [5]. However, the
intracellular signalling pathways activated by the allergens
that induce DC maturation are not completely understood.
The promoter region of genes encoding key proteins of
the immune system, such as the major histocompatibility
complex class I and II molecules, cytokines and their re-
ceptors, or cell adhesion molecules, contain binding sites
for the transcription nuclear factor kappa B (NF-κB) [27].
Five members of the mammalian NF-κB/Rel family, p50,
p52, p65 (RelA), RelB, and cRel, have been cloned and
characterized, and in resting cells, NF-κB proteins are lo-
calized in the cytosol in association with inhibitory pro-
teins called IκB [10]. Cell activation by various inducers
results in IκB protein phosphorylation and degradation,
which in turns leads to NF-κB protein translocation to the
nucleus, where it upregulates NF-κB-dependent gene ex-
pression [18].
We have previously reported that in a fetal skin DC
(FSDC) line, which exhibits functional characteristics of a
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DC precursor, lipopolysaccharide (LPS) and granulocyte-
macrophage colony-stimulating factor activate the tran-
scription factor NF-κB [12, 13]. The aim of this study was
to investigate whether the strong sensitizer, 2,4-dinitroflu-
orobenzene (DNFB), activates NF-κB in skin DC and to
determine which members of this protein family are
translocated from the cytosol to the nucleus after exposure
of skin DC to DNFB.
Material and methods
Materials
Rabbit anti-human NF-κB p65 was from Serotec (Oxford, UK)
and rabbit anti-IκB-α polyclonal antibody was from New England
BioLabs (Beverly, Mass.). NF-κB consensus oligonucleotide, goat
anti-mouse NF-κB cRel, rabbit anti-human NF-κB RelB, rabbit
anti-human NF-κB p50, and rabbit anti-human NF-κB p52 were
obtained from Santa Cruz Biotechnology (Santa Cruz, Calif.).
Mouse monoclonal antibody against actin and protease inhibitor
cocktail were purchased from Roche (Carnaxide, Portugal). 32P-La-
belled γ-ATP, the ECL Western blotting analysis system, X-ray
films, T4 polynucleotide kinase and poly(dI-dC).poly(dI-dC) were
from Amersham Pharmacia Biotech (Carnaxide, Portugal). Horse-
radish peroxidase-conjugated swine anti-rabbit and horseradish
peroxidase-conjugated swine anti-goat were from DAKO (Copen-
hagen, Denmark). Horseradish peroxidase-conjugated goat anti-
mouse was from Pierce (Rockford, Ill.). DNFB was purchased
from Sigma-Aldrich Química (Madrid, Spain), fetal calf serum
was from Biochrom (Berlin, Germany), and trypsin from Gibco
(Paisley, UK). All other reagents were from Sigma Chemical Co
(St. Louis, Mo.).
Cell culture
The FSDC cell line, which has been shown to have antigen-
presenting capacity to T cells, was kindly supplied by Dr. G.
Girolomoni [17]. The cells were cultured in endotoxin-free Is-
cove’s medium supplemented with 10% (v/v) fetal calf serum, 1%
(w/v) glutamine, 3.02 g/l sodium bicarbonate, 100 µg/ml strepto-
mycin and 100 U/ml penicillin. For Western blotting and the elec-
trophoretic mobility shift assay (EMSA), FSDC were plated at
2×106 cells/well in six-well culture dishes for 24 h prior to treat-
ment.
Western blot analysis
For immunodetection of IκB-α, p50, p52, p65, cRel and RelB,
FSDC were treated with culture medium (control) or with DNFB
(1 µg/ml) for 2, 5, 15 and 30 min. Proteins of the cytosolic fraction
were obtained after harvesting the cells in 10 mM NaCl, 3 mM
MgCl2, 0.5% (v/v) Nonidet P-40, 1 mM dithiothreitol, 0.1 mM
PMSF, 10 mM Tris-HCl, pH 7.5, and protease inhibitor cocktail.
The lysates were incubated on ice for 15 min and the cytosolic pro-
teins were isolated from the supernatant obtained after centrifuga-
tion at 2300 g for 10 min. In order to obtain proteins of the nuclear
fraction the pellet obtained was resuspended in 300 mM NaCl, 
3 mM MgCl2, 20% (v/v) glycerol, 1 mM dithiothreitol, 0.1 mM
PMSF, 0.2 mM EDTA, 20 mM HEPES buffer (pH 7.5), and pro-
tease inhibitor cocktail, incubated on ice for 1 h, and centrifuged at
12,000 g for 20 min. The supernatant containing the nuclear pro-
teins was collected, and the protein concentration was determined
using the bicinchoninic acid method. Total cell lysates were ob-
tained after harvesting the cells in a sonication buffer containing
10 mM Tris-HCl, pH 7.5, 0.32 M sucrose, 1 mM EDTA, 1 mM
dithiothreitol, 0.1 mM PMSF and protease inhibitor cocktail. The
lysates were then incubated on ice for 30 min and sonicated on ice
at low amplitude (four times for 4 s at 20 µm peak to peak) to dis-
rupt the cells and release the NF-κB proteins, and the protein con-
centration was determined using the bicinchoninic acid method.
Protein samples were denatured and separated on a 15% (v/v)
SDS-PAGE, and transferred to a PVDF membrane. The mem-
branes were blocked with 5% (w/v) dried milk in Tris-buffered
saline with 0.1% (v/v) Tween 20 for 1 h. IκB-α, p50, p52, p65,
cRel and RelB proteins were detected by incubation with a rabbit
polyclonal anti-IκB-α antibody (1:1000), a rabbit polyclonal anti-
human p50 antibody (1:100), a rabbit polyclonal anti-human p52
antibody (1:500), a rabbit polyclonal anti-human p65 antibody
(1:1000), a goat polyclonal anti-mouse c-Rel antibody (1:500) and
a rabbit polyclonal anti-human RelB antibody (1:500) for 1 h, fol-
lowed by incubation with a horseradish peroxidase-conjugated
swine anti-rabbit antibody (1:1000), a horseradish peroxidase-con-
jugated swine anti-goat antibody (1:5000) or a horseradish peroxi-
dase-conjugated goat anti-mouse antibody (1:25,000). The im-
munocomplexes were visualized by the ECL chemiluminescence
method. To demonstrate equivalent protein loading the membranes
were stripped and reprobed with an anti-actin antibody (1:10,000).
EMSA
FSDC were treated for 15 min, 30 min and 1 h with DNFB (1 µg/
ml). The cells were then washed with PBS and lysed in 10 mM
NaCl, 3 mM MgCl2, 0.5% (v/v) Nonidet P-40, 1 mM dithiothreitol,
0.1 mM PMSF, 10 mM Tris-HCl, pH 7.5, and protease inhibitor
cocktail. The lysates were incubated on ice, for 15 min, and cen-
trifuged at 2300 g for 10 min. The resulting pellet was resuspended
in 300 mM NaCl, 3 mM MgCl2, 20% (v/v) glycerol, 1 mM dithio-
threitol, 0.1 mM PMSF, 0.2 mM EDTA, 20 mM HEPES buffer
(pH 7.5), and protease inhibitor cocktail, incubated on ice for 1 h,
and centrifuged at 12,000 g for 20 min. The supernatant containing
the nuclear proteins was collected, and the protein concentration
was determined using the bicinchoninic acid method. The EMSA
method used was similar to that described previously [18], with
slight modifications. The probes consisted of a double-stranded
oligonucleotide containing the consensus binding sequence for
NF-κB (5′-AGT TGA GGG GAC TTT CCC AGG C-3′) end-la-
belled with [γ-32P]ATP using T4 polynucleotide kinase. Typical
binding reactions consisted of 20 µg nuclear extract, about
100,000 cpm [γ-32P]-labelled oligonucleotide, 100 µg/ml poly(dI-
dC).poly(dI-dC) in a buffer containing 20 mM HEPES (pH 7.9), 
1 mM MgCl2, 4% (w/v) Ficoll 400, 0.5 mM dithiothreitol, 50 mM
KCl, and 1 mg/ml bovine serum albumin, and were incubated at
room temperature for 45 min. Binding reactions were separated on
7% (v/v) nondenaturing polyacrylamide gels in a buffer system
containing 0.044 M Tris-base (pH 8.0), 44.5 mM boric acid and 
1 mM EDTA at a constant 150 V for 2 h and 15 min at room tem-
perature. The gels were transferred to Whatman paper, dried, and
subjected to autoradiography. In competition experiments, unla-
beled oligonucleotide was added to the nuclear extracts for 1 h be-
fore the addition of the radiolabeled probe. To detect supershifted
bands, anti-p50, anti-p52, anti-p65, anti-cRel and anti-RelB anti-
bodies (2 µg) were incubated with the nuclear extracts for 1 h be-
fore the addition of radiolabeled probe.
Data analysis
The results are presented as means±SEM of the indicated number
of experiments. The results were analysed using the unpaired Stu-
dent’s t-test. The significance level was 0.05.
Results
DNFB induces NF-κB binding to DNA in FSDC
Stimulation of FSDC with DNFB (1 µg/ml) induced a time-
dependent increase in NF-κB binding to DNA (not
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shown). Maximal NF-κB binding to DNA (Fig.1) was ob-
served within 15 min (lane 2). Supershift experiments us-
ing antibodies against the p50 (lane 4), p52 (lane 5), p65
(lane 6) and Rel B (lane 7) NF-κB subunits showed a de-
crease in NF-κB complex formation in cells stimulated
with DNFB. In contrast, supershift experiments using an
antibody against the cRel NF-κB subunit was without ef-
fect (lane 8). As control for the gel shift assays, unlabeled
oligonucleotide (100-fold excess) was used (lane 3) which
inhibited NF-κB complex formation.
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Fig.1 DNFB induced NF-κB activation in FSDC. FSDC (2×106
cells) were incubated in culture medium alone (Control, lane 1),
or in the presence of 1 µg/ml DNFB for 15 min (lane 2). Nuclear
extracts were subjected to EMSA as described in the experimen-
tal procedures. Supershift experiments were done using specific
anti-p50, anti-p52, anti-p65, anti-RelB and anti-cRel antibodies
(lanes 4–8). To demonstrate the specificity of the induced bands,
binding was carried out in the presence of a molar excess (100×) of
nonradioactive NF-κB consensus oligonucleotide (lane 3). The gel
shown is representative of three gels yielding similar results
Fig.2 DNFB induced cytosolic degradation of IκB-α in FSDC.
FSDC (2×106 cells) were incubated with culture medium alone
(Control) or with DNFB (1 µg/ml) for the times indicated in the
figure. Total cell extracts were electrophoresed through SDS-
PAGE and subjected to Western blot analysis using anti-IκB-α an-
tibody as described in the experimental procedures. The blot
shown is representative of three blots yielding similar results. Each
bar represents the mean±SEM from at least three experiments.
*P<0.05, ***P<0.001
Fig.3a,b DNFB induced protein NF-κB p50 translocation from
the cytosol into the nucleus in FSDC. FSDC (2×106 cells) were 
incubated with culture medium alone (Control) or with DNFB 
(1 µg/ml) for the times indicated in the figure. Cytosolic and nu-
clear cells extracts were electrophoresed through SDS-PAGE and
subjected to Western blot analysis using anti-p50 antibody as de-
scribed in the experimental procedures. The blots shown are repre-
sentative of three blots yielding similar results. Each bar represents
the mean±SEM from at least three experiments. *P<0.05, **P<
0.01 (n.s. not significant)
DNFB induces the degradation 
of cytosolic IκB-α protein in FSDC
To determine whether DNFB induced IκB-α degradation,
the levels of IκB-α protein in total cell extracts were de-
termined by Western blot analysis. As shown in Fig.2,
treatment of cells with 1 µg/ml DNFB for 5, 15 and 
30 min caused a reduction in the total amount of the pro-
tein in FSDC (from 100% in control cells to 74.6±1.9%
after 30 min DNFB incubation).
DNFB induces the translocation of the NF-κB p50, 
p52 and RelB proteins from the cytosol to the nucleus 
in FSDC
In order to determine which members of the NF-κB fam-
ily are activated upon stimulation of FSDC with DNFB,
cytosolic and nuclear extracts were subjected to Western
blot analysis, using antibodies against the proteins p50,
p52, p65, RelB and cRel. As shown in Figs. 3, 4 and 5,
stimulation of cells with DNFB (1 µg/ml) resulted in a
significant reduction in the cytosolic levels and an in-
crease in the nuclear levels of NF-κB proteins p50, p52
and RelB, but with different kinetics. Indeed, transloca-
tion of p50 and p52 was observed after 5 min incubation
with DNFB (Fig.3a and Fig.4a), whereas translocation of
RelB was observed after 15 min incubation with DNFB
(Fig.5a). Treatment of FSDC with DNFB (1 µg/ml) did
not significantly modify the levels of cRel protein in the
cytosol or in the nucleus (Fig.6).
DNFB decreases the NF-κB protein p65 expression 
in total cell lysates of FSDC
In contrast to the results observed for the p50, p52 and
RelB proteins, DNFB induced a decrease in p65 protein
expression in both the nucleus and the cytosol of FSDC
(Fig.7). We next determined p65 protein expression in to-
tal cell lysates obtained from FSDC stimulated with
DNFB for 5, 15 and 30 min and 1 h (Fig.8). A decrease in
p65 protein expression was observed mainly after 1 h in-
cubation with DNFB (from 100% to 59.1±2.8%; Fig. 8).
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Fig.4a,b DNFB induced protein NF-κB p52 translocation from
the cytosol into the nucleus in FSDC. FSDC (2×106 cells) were in-
cubated with culture medium alone (Control) or with DNFB 
(1 µg/ml) for the times indicated in the figure. Cytosolic and nu-
clear cells extracts were electrophoresed through SDS-PAGE and
subjected to Western blot analysis using anti-p52 antibody as de-
scribed in the experimental procedures. The blots shown are repre-
sentative of three blots yielding similar results. Each bar represents
the mean±SEM from at least three experiments. *P<0.05 (n.s. not
significant)
Fig.5a,b DNFB induced protein NF-κB RelB translocation from
the cytosol into the nucleus in FSDC. FSDC (2×106 cells) were
incubated with culture medium alone (Control) or with DNFB 
(1 µg/ml) for the times indicated in the figure. Cytosolic and nu-
clear cells extracts were electrophoresed through SDS-PAGE and
subjected to Western blot analysis using anti-RelB antibody as de-
scribed in the experimental procedures. The blots shown are repre-
sentative of three blots yielding similar results. Each bar represents
the mean±SEM from at least three experiments. *P<0.05, **P<
0.01 (n.s. not significant)
Discussion
In the present work, we showed that exposure of FSDC 
to DNFB induced degradation of IκB-α protein with sub-
sequent translocation of the NF-κB proteins (p50, p52 and
RelB) into the nucleus (Figs. 2, 3, 4 and 5), although with
different kinetics, to bind DNA (Fig.1). In contrast, 
NF-κB protein p65 was diminished in both the nucleus
and the cytosol of FSDC (Fig.7) due to a decrease in p65
protein expression observed in total cell lysates after 1 h
incubation with DNFB (Fig.8).
Previous in vitro studies have shown that skin contact
sensitizers induce DC maturation [3]. However, the intra-
cellular signalling pathways by which DNFB induces 
DC maturation are not known. The promoter region of a
large number of genes involved in the inflammatory re-
sponse contains binding sites for NF-κB [27]. More than
150 NF-κB-responsive genes have been identified, in-
cluding genes coding for cytokines, chemokines, cell ad-
hesion molecules and growth factors [27]. However, de-
pending on the cell and the stimulus, the NF-κB pathway
displays the capacity to activate only a subset of the total
repertoire of NF-κB-responsive genes [23]. In macro-
phages and DC the NF-κB pathway responds to different
stimuli by activating, in a cell-specific manner, unique
signalling pathways and subsets of NF-κB target genes
[4]. We have previously reported that in FSDC, LPS and
granulocyte-macrophage colony-stimulating factor induce
IκB-α degradation, NF-κB translocation into the nucleus
and iNOS expression [12, 13], indicating that in skin DC
the activation of NF-κB is a crucial step in DC matura-
tion. Accordingly, it has recently been demonstrated that
effective antigen presentation by DC is NF-κB-dependent
[33].
In normal epidermis, the NF-κB proteins p50 and p52,
in addition to p65, are mostly expressed in the cytoplasm
of basal cells [7, 19], and the NF-κB proteins have been
found to be involved in DC differentiation and maturation
[1, 15, 25, 26, 31]. It has also recently been demonstrated
that the NF-κB signal transduction pathway is involved in
the survival and maturation of LPS-stimulated human
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Fig.7a,b DNFB induced a decrease in protein NF-κB p65 ex-
pression in both the nucleus and the cytosol of FSDC. FSDC
(2×106 cells) were incubated with culture medium alone (Control)
or with DNFB (1 µg/ml) for the times indicated in the figure. Cy-
tosolic and nuclear cells extracts were electrophoresed through
SDS-PAGE and subjected to Western blot analysis using anti-p65
antibody as described in the experimental procedures. The blots
shown are representative of three blots yielding similar results.
Each bar represents the mean±SEM from at least three experi-
ments. *P<0.05, **P<0.01,***P<0.001 (n.s. not significant)
Fig.6a,b DNFB did not induce protein NF-κB cRel translocation
from the cytosol into the nucleus in FSDC. FSDC (2×106 cells)
were incubated with culture medium alone (Control) or with
DNFB (1 µg/ml) for the times indicated in the figure. Cytosolic
and nuclear cells extracts were electrophoresed through SDS-
PAGE and subjected to Western blot analysis using anti-cRel anti-
body as described in the experimental procedures. The blots shown
are representative of three blots yielding similar results. Each bar
represents the mean±SEM from at least three experiments (n.s. not
significant)
monocyte-derived DC [2]. The NF-κB member RelB is
also involved in DC differentiation [11, 32] and in the
transactivation of genes of central importance for func-
tional antigen-presenting cells [8, 21, 29]. Those results
demonstrate that the NF-κB signalling pathway is of ma-
jor importance in DC.
The DNFB-induced signalling pathway(s) responsible
for NF-κB activation have not yet been identified. Recent
studies have shown that an early molecular event during
the activation of antigen-presenting cells by contact sensi-
tizers, namely DNFB, is the induction of tyrosine phos-
phorylation [20, 24]. Moreover, it has also been demon-
strated that upregulation of CD80, CD86 and CD83 in-
duced by DNFB [30] is coupled to the phosphorylation of
p38 mitogen-activated protein kinase (p38 MAPK) [3].
Almost all signals that lead to activation of NF-κB con-
verge on a high molecular weight complex that contains a
serine-specific IκB kinase (IKK). IKK contains two re-
lated kinases, IKKα and IKKβ, that are active as a dimer.
Activation of IKK leads to the phosphorylation of two
specific serines near the N terminus of IκB-α, which tar-
gets IκB-α for ubiquitination and degradation by the pro-
teasome. The unmasked NF-κB can then enter the nucleus
to activate target gene expression [16]. The p38 MAPK
pathway has been shown to contribute to NF-κB-medi-
ated transactivation [6, 9]. These results suggest that in
FSDC DNFB may activate protein kinases, namely p38
MAPK, which in turn activate the IκB kinase complex
leading to NF-κB activation.
We demonstrated that DNFB selectively translocates,
with different kinetics, the NF-κB proteins p50, p52 and
RelB into the nucleus of skin DC (Figs. 3, 4 and 5), but in-
duced a decrease in p65 protein expression in total cell ly-
sates after 1 h of incubation (Fig.8). Furthermore, DNFB
was without effect on the expression of cRel (Fig.6). This
differential regulation of the NF-κB subunits probably
contributes to the specificity and selectivity of the NF-κB
response. In fact, the target genes activated by NF-κB will
vary depending upon the cellular context, and this is
achieved through a combination of regulatory mecha-
nisms. The selective activation of NF-κB complexes, with
subtle differences in DNA-binding specificities, results in
the targeting of different promoters and enhancers [28].
Moreover, NF-κB transactivation and DNA binding can
also be regulated through phosphorylation of NF-κB it-
self, namely by p38 MAPK, protein kinase A and casein
kinase II [22].
The differential expression and activation of various
NF-κB factors in DC by different skin sensitizers should
have profound biological consequences because it directly
affects the function of NF-κB factors and defines the set
of κB-responsive genes under transcription and conse-
quently may affect the antigen-presenting capacity of DC.
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